C. Comarmond

604 total citations
8 papers, 50 citations indexed

About

C. Comarmond is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Infectious Diseases. According to data from OpenAlex, C. Comarmond has authored 8 papers receiving a total of 50 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Rheumatology and 2 papers in Infectious Diseases. Recurrent topics in C. Comarmond's work include Vasculitis and related conditions (5 papers), COVID-19 Clinical Research Studies (2 papers) and Systemic Lupus Erythematosus Research (2 papers). C. Comarmond is often cited by papers focused on Vasculitis and related conditions (5 papers), COVID-19 Clinical Research Studies (2 papers) and Systemic Lupus Erythematosus Research (2 papers). C. Comarmond collaborates with scholars based in France and Tunisia. C. Comarmond's co-authors include Matthieu Resche‐Rigon, A. Mékinian, David Saadoun, P. Cacoub, M. Lambert, D. Sène, Yasmina Ferfar, Stéphane Mouly, Achille Aouba and Blanca Amador-Borrero and has published in prestigious journals such as Annals of the Rheumatic Diseases, Autoimmunity Reviews and Journal of Autoimmunity.

In The Last Decade

C. Comarmond

8 papers receiving 49 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Comarmond France 3 23 22 10 9 7 8 50
Alice Bartoletti Italy 3 40 1.7× 29 1.3× 10 1.0× 11 1.2× 3 0.4× 8 52
Marcin Milchert Poland 5 44 1.9× 35 1.6× 8 0.8× 27 3.0× 4 0.6× 26 78
Sapan C Pandya India 4 20 0.9× 50 2.3× 8 0.8× 10 1.1× 5 0.7× 20 67
Vanessa Quick United Kingdom 5 58 2.5× 45 2.0× 18 1.8× 19 2.1× 7 1.0× 12 93
Lee Ping Chew Malaysia 5 16 0.7× 6 0.3× 8 0.8× 24 2.7× 3 0.4× 26 82
S. Madaule France 3 17 0.7× 22 1.0× 10 1.0× 11 1.2× 1 0.1× 9 64
Thomas Le Gallou France 4 37 1.6× 23 1.0× 10 1.0× 8 0.9× 13 1.9× 10 63
Ludovic Tréfond France 4 7 0.3× 19 0.9× 9 0.9× 7 0.8× 2 0.3× 9 57
Soumaya El Mahou France 4 6 0.3× 36 1.6× 6 0.6× 10 1.1× 4 0.6× 8 61
Josep María Cruzado Garrit Spain 4 41 1.8× 7 0.3× 16 1.6× 11 1.2× 11 1.6× 7 74

Countries citing papers authored by C. Comarmond

Since Specialization
Citations

This map shows the geographic impact of C. Comarmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Comarmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Comarmond more than expected).

Fields of papers citing papers by C. Comarmond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Comarmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Comarmond. The network helps show where C. Comarmond may publish in the future.

Co-authorship network of co-authors of C. Comarmond

This figure shows the co-authorship network connecting the top 25 collaborators of C. Comarmond. A scholar is included among the top collaborators of C. Comarmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Comarmond. C. Comarmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lopes, Amanda, K. Champion, Blanca Amador-Borrero, et al.. (2023). Drug–Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality?. Journal of Clinical Medicine. 12(22). 7120–7120. 12 indexed citations
2.
Bonnin, Sophie, Aline Frazier, Caroline Roos, et al.. (2023). Impairment of central retinal artery hemodynamics in affected and fellow eyes in giant cell arteritis patients with unilateral vision loss. Autoimmunity Reviews. 22(3). 103272–103272. 1 indexed citations
3.
Jachiet, Vincent, Léo Plaçais, Noémie Abisror, et al.. (2021). Tocilizumab and COVID-19: Timing of administration assessment. Infectious Diseases Now. 52(1). 31–34. 2 indexed citations
4.
Comarmond, C., Mathilde Leclercq, Gaëlle Leroux, et al.. (2020). 2019 Novel Coronavirus Disease (COVID-19) in Patients with Large-Vessels Vasculitis: Single-centre Experience in Paris. HAL (Le Centre pour la Communication Scientifique Directe). 72. 2–2. 1 indexed citations
5.
Vautier, Mathieu, Axelle Dupont, Hubert de Boysson, et al.. (2020). Prognosis of large vessel involvement in large vessel vasculitis. Journal of Autoimmunity. 108. 102419–102419. 16 indexed citations
6.
Comarmond, C., et al.. (2020). Abstract Supplement ACR Convergence 2020. Arthritis & Rheumatology. 72(S10). 1–4259. 14 indexed citations
7.
Mirouse, Adrien, C. Comarmond, Lucie Biard, et al.. (2018). FRI0484 Overall survival and mortality risk factors in takayasu's arteritis: a multicenter study of 318 patients. Annals of the Rheumatic Diseases. 77. 770–770. 2 indexed citations
8.
Pazzola, Giulia, Francesco Muratore, Nicolò Pipitone, et al.. (2017). AB0563 Rituximab in patients with takayasu arteritis: a seven patients experience. Annals of the Rheumatic Diseases. 76. 1247–1248. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026